What Is the Survival Rate of an AVM?

A brain AVM is a tangle of blood vessels in which arteries connect directly to veins, and most people who have one live for many years after it is found. Its real threat is a sudden bleed in the brain, so survival depends less on a single percentage than on how likely a bleed is and how a person comes through one. That makes an AVM’s outlook unusually changeable, because treatment, pregnancy and the AVM’s own features can raise or lower the risk over time.

How AVMs Affect Long-Term Survival

Compared with people of the same age and sex, people diagnosed with a brain AVM have about 85% of the expected survival 10 years later.1PubMed. Long-term excess mortality in 623 patients with brain arteriovenous malformations By 30 years, that falls to about 69%.1PubMed. Long-term excess mortality in 623 patients with brain arteriovenous malformations The gap is real, and it is tied to the AVM itself: in a group of 623 patients followed for decades, about half of all deaths were linked to the AVM.1PubMed. Long-term excess mortality in 623 patients with brain arteriovenous malformations In another long-term study, about 13 in 100 people died of any cause during follow-up and about 9 in 100 died from the AVM, on average more than 10 years after diagnosis.2PubMed. A population-based study of brain arteriovenous malformation: long-term treatment outcomes Many AVM deaths come years after diagnosis, though the first months carry their own risk.

An 85% figure doesn’t mean 15 in 100 people die from the AVM. It compares the group’s deaths with those of the general population, and part of the gap comes from AVM bleeds while part comes from other health problems.

The early months carry their own risk. In the 6 months after an AVM is found, about 6 in 100 people with an AVM that had not bled died, compared with about 12 in 100 when it was found because it had bled.3PubMed. Sudden Prehospital Deaths From Brain Arteriovenous Malformations: A Population-Based Study

Figures differ from one study to the next. Studies that include people diagnosed after a bleed push death rates up, while studies of AVMs found by chance look more reassuring. Older studies may also reflect less effective treatment than today’s.

Survival After an AVM Bleeds

A rupture, when the tangled vessels tear and bleed into the brain, is the main way an AVM causes death. In one hospital series, about 21 in 100 people died after an AVM bleed, 45 in 100 had new or worse nerve problems, and 35 in 100 recovered completely.4PubMed. Clinical outcome following cerebral AVM hemorrhage Large AVM studies more often quote a death risk of about 10 in 100 for a first bleed.5PubMed Central. Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium

Among people who survived to be assessed, nearly half had no lasting deficit and another 37 in 100 were fully independent in daily life.6PubMed. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation About 13 in 100 were moderately disabled and 3 in 100 severely disabled.6PubMed. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation

The classic warning sign is a sudden, severe headache unlike any before. Vomiting, weakness on one side, confusion, trouble speaking or a seizure can also signal a bleed. Call emergency services right away rather than waiting to see if it passes, and tell the responders the person has a known AVM.

Some bleeds happen before anyone knows there is an AVM. Among children whose first bleed came from an AVM nobody knew about, about 12 in 100 died from that bleed.7PubMed. Acute fatal hemorrhage from previously undiagnosed cerebral arteriovenous malformations in children: a single-center experience No clear trigger like sport or injury was found, and some of these children collapsed before reaching hospital.7PubMed. Acute fatal hemorrhage from previously undiagnosed cerebral arteriovenous malformations in children: a single-center experience Avoiding activities may therefore not prevent a bleed, though your doctor may give specific advice.

How Often AVMs Bleed Each Year

These yearly figures come from groups of people followed over time, so they describe the group and can’t say whether one particular AVM will bleed this year. Two people with the same stated risk can have very different AVMs. Most studies also count bleeds only after diagnosis, so the true risk before an AVM is found is hard to measure, and the numbers are best treated as estimates with a range.

Some features raise the risk. An AVM that has already bled is about twice as likely to bleed again.9PubMed. The natural history and predictive features of hemorrhage from brain arteriovenous malformations AVMs that drain into deep veins or have a bulging weak spot called an aneurysm may also be about twice as likely to bleed.9PubMed. The natural history and predictive features of hemorrhage from brain arteriovenous malformations AVMs that drain through a single vein were more likely to bleed after diagnosis.10PubMed. Hemorrhage risk of cerebral arteriovenous malformations before and during the latency period after GAMMA knife radiosurgery

A small yearly risk adds up. At about 2 in 100 a year, the chance of at least one bleed over 10 years is roughly 1 in 5, and over decades it grows further, which matters most for young people.

Treating an Unruptured AVM Versus Watching It

In a large trial of people with unruptured AVMs, those managed with medicines and monitoring had far fewer strokes or deaths than those who had procedures.11PubMed Central. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial After about 30 months, about 15 in 100 people being monitored had died or were disabled, compared with about 46 in 100 after treatment.11PubMed Central. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial Over about 4 years, the yearly rate of death or stroke was about 3 in 100 with monitoring and about 12 in 100 with treatment.12PubMed. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial The procedures themselves cause strokes and other nerve problems.11PubMed Central. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial

The trial enrolled people whose AVM had never bled and whose doctors were genuinely unsure whether treatment would help. It does not speak for AVMs where treatment was clearly advisable. People with AVMs that doctors already judged easy or urgent to treat were less likely to be entered, so before assuming the result applies to you, ask whether your AVM resembles those in the trial in size, location and grade.

Other evidence suggests treatment helps some people. In a large later study, treated people were more likely to stay free of bleeding, about 96 in 100 at 5 years compared with 89 in 100 with monitoring.13JAMA Network Open. Interventional Treatment vs Conservative Management of Unruptured Brain Arteriovenous Malformations That benefit was not seen for high-grade AVMs or ones with a spread-out tangle.13JAMA Network Open. Interventional Treatment vs Conservative Management of Unruptured Brain Arteriovenous Malformations The best choice depends heavily on the AVM’s size, location and grade.

The trial results are debated. Follow-up lasted only a few years, while bleeding risk adds up over decades. Procedure risks come early and the benefits may come later.

Medical management is not doing nothing. It means regular scans and treating symptoms: seizures are treated with medicines, headaches are managed, and blood pressure control is often encouraged. The plan can change if the AVM bleeds or grows.

Risks of Surgery to Remove an AVM

Doctors rate AVMs with the Spetzler-Martin grade, from 1 to 5, based on size, whether the AVM drains into deep veins and whether it sits in a key brain area. Complications after surgery rise steadily with grade.14PubMed. Determinants of neurological outcome after surgery for brain arteriovenous malformation For grade 3 AVMs, about 4 in 100 died after surgery and 4 in 100 had permanent new problems.15PubMed. Spetzler-Martin Grade III arteriovenous malformations: surgical results and a modification of the grading scale The combined risk ranged from about 3 in 100 for small grade 3 AVMs to about 15 in 100 for medium ones in key brain areas.15PubMed. Spetzler-Martin Grade III arteriovenous malformations: surgical results and a modification of the grading scale

Lower grades (1 and 2) are small, in less critical areas, and carry a considerably lower surgical risk, so surgery is often a reasonable option for them. Grades 4 and 5 are large, deep or in critical brain areas, and surgery on them is risky enough that doctors often advise against it unless the AVM has bled or is causing serious problems. Grade 3 is the middle group where the choice is least clear, which is why its figures vary so much with the AVM’s particular size and location.

Many problems after surgery improve. Right after surgery, about 41 in 100 people had a new nerve problem.14PubMed. Determinants of neurological outcome after surgery for brain arteriovenous malformation About a year later, 38 in 100 still had one, but only 6 in 100 were disabling.14PubMed. Determinants of neurological outcome after surgery for brain arteriovenous malformation

The benefit is that successful removal ends the bleeding risk almost immediately. A scan of the blood vessels confirms the AVM is fully gone.

Risks of Radiosurgery and Embolization

Radiosurgery aims precise radiation at the AVM so its vessels slowly scar shut, without cutting the skull. The AVM closes off completely in about 70 to 85 in 100 people, usually after 3 to 5 years.16PubMed Central. Gamma Knife Radiosurgery For Brain Vascular Malformations: Current Evidence And Future Tasks While waiting, bleeding risk fell by about half compared with before treatment.17PubMed. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations Once the AVM closed off, bleeding risk dropped by about 88%.17PubMed. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations

During the wait, follow-up scans track whether the AVM is closing. Some bleeding risk remains until it fully closes, so new symptoms should be reported promptly.

Focused radiation is generally used for smaller AVMs, since the dose needed to close a large one would risk damaging too much healthy brain. It is often chosen for AVMs deep in the brain or in key areas where surgery would be dangerous. Larger AVMs are less likely to close completely, and doctors sometimes treat them in stages or combine methods.

Embolization means threading a thin tube through blood vessels to block the AVM with a glue-like material. Deaths from embolization ranged from about 1 to 2 in 100.18PubMed. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors19PubMed. Embolization of brain arteriovenous malformations with intent to cure: a systematic review When used alone to try to cure the AVM, about 1 in 4 people had a complication, most often a bleed.19PubMed. Embolization of brain arteriovenous malformations with intent to cure: a systematic review In one series, only 2 in 100 survivors were seriously disabled at last check.20PubMed. Postembolization neurological deficits in cerebral arteriovenous malformations: stratification by arteriovenous malformation grade

Glue treatment is often done before surgery or focused radiation to make them safer, and several sessions may be needed. Combining treatments for grade 3 AVMs kept deaths around 1 in 100 in one center.21Journal of NeuroInterventional Surgery. O-011 Multimodality management of spetzler-martin grade III arteriovenous malformations

Can an AVM Come Back After Treatment

After complete surgical removal, about 3 in 100 adults saw the AVM return, but in children about 1 in 10 did.22PubMed. Recurrent Brain Arteriovenous Malformations (AVMs): A Systematic Review In one hospital, 5 of 17 children had regrowth compared with 1 of 118 adults.23PubMed Central. Recurrence of arteriovenous malformations of the brain after complete surgical resection. Kuopio University Hospital experience and systematic review of the literature Regrowth often showed up years later, on average about 4 to 7 years after surgery.22PubMed. Recurrent Brain Arteriovenous Malformations (AVMs): A Systematic Review23PubMed Central. Recurrence of arteriovenous malformations of the brain after complete surgical resection. Kuopio University Hospital experience and systematic review of the literature In children, AVMs closed by focused radiation rarely returned, under 1 in 100, compared with about 8.5 in 100 after surgery.24Journal of Neurosurgery: Pediatrics. Return of the lesion: a meta-analysis of 1134 angiographically cured pediatric arteriovenous malformations

A child’s brain and blood vessels are still growing, so vessels that look removed may later form again. That is why follow-up is planned for longer.

Children often need repeat scans for years. Some returning AVMs were only found when they bled, so it’s worth asking how long your scan schedule should run.

AVMs and Pregnancy

In one North American group, the yearly bleed rate was about 5.7 in 100 for pregnant women compared with 1.3 in 100 for women who were not pregnant.25PubMed. Hemorrhage Risk of Brain Arteriovenous Malformations During Pregnancy and Puerperium in a North American Cohort Another estimate put the yearly rate during pregnancy at about 9 in 100.26PubMed. Risk for Brain Arteriovenous Malformation Rupture During Pregnancy and Puerperium One study found no higher risk, with about 2.7 bleeds per 100 pregnancies.5PubMed Central. Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium In that study, 1 of 12 women whose AVM bled during pregnancy died.5PubMed Central. Risk of cerebral arteriovenous malformation rupture during pregnancy and puerperium

The studies disagree partly because pregnancy is a short window, so a few bleeds in a small group of women can swing the yearly rate noticeably up or down. They also differ in whether they count women whose AVM was already known, which changes how risky the group looks. Doctors generally treat pregnancy as a time for extra caution instead of relying on any one figure.

If you’re thinking about pregnancy, talk to a neurosurgeon and an obstetrician before trying to conceive. Some women choose treatment first. Ask about delivery planning and the weeks after birth.

Seizures and Quality of Life

An AVM can irritate the surrounding brain tissue, and abnormal electrical activity from that tissue produces seizures. Seizures can be the first sign of an AVM, even when it has never bled, and this is how many AVMs are found. The type varies from a brief spell of unusual sensation or movement to a full convulsion.

About 60 to 70 in 100 people with AVM-related seizures become seizure-free with medicine.27Exploration of Neuroscience. Current advances in epilepsy among patients with arteriovenous malformations Over 5 years, the chance of 2 seizure-free years was similar with treatment or monitoring, about 52 and 57 in 100.28PubMed Central. Seizure risk with AVM treatment or conservative management: prospective, population-based study Surgery had the best seizure control, about 78 in 100, compared with 63 in 100 for focused radiation and 49 in 100 for glue treatment.29PubMed. Seizure control for intracranial arteriovenous malformations is directly related to treatment modality: a meta-analysis New seizures were also more common after glue treatment.29PubMed. Seizure control for intracranial arteriovenous malformations is directly related to treatment modality: a meta-analysis

Many people need only one medicine. Driving rules after a seizure vary by place, so check local law.